The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen (Q34482074)

2 August 2017

1 reference

title

The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen (English)

1 reference

2 August 2017

Jonathan L Bramson

1

0 references

author name string

Yong-Hong Wan

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

75-85

1 reference

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Functional genomics of Neisseria meningitidis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Signature-tagged mutagenesis in the identification of virulence genes in pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

DNA and RNA-based vaccines: principles, progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Genetically modified viruses: vaccines by design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Nonviral vectors in the new millennium: delivery barriers in gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Adenovirus vectors for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Applications of pox virus vectors to vaccination: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Adenoviruses as vectors for delivering vaccines to mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid-formulated DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

An autologous oral DNA vaccine protects against murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Immunology. Licence to kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

MHC class II-restricted presentation of intracellular antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Class II MHC molecules can use the endogenous pathway of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Heteroclitic immunization induces tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

A new era for cancer immunotherapy based on the genes that encode cancer antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.75

21 January 2018

Identifiers

DOI

10.1517/14712598.2.1.75

1 reference

2 August 2017

1 reference